Edward Rosfjord

7PUBLICATIONS
120CO-AUTHORS
Aircraft performance and flight control systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesBiomaterialsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers.

Jason J Zoeller, Ravinder Tammali, Roger B Dodd

|May 14, 2025
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.

Keith Abayasiriwardana, Lei Wu, Hanane Laklai

|Feb 01, 2023
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and Toxicity.

Arnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari

|Jul 06, 2022
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.

Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang

|Nov 05, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia.

Yoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas

|Aug 05, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers.

Edmund I Graziani, Matthew Sung, Dangshe Ma

Pageof 2

Frequent Collaborators

3 joint publications

Divya Mathur

3 joint publications

Puja Sapra

3 joint publications

Frank Loganzo

3 joint publications

Christopher O'Donnell